Skip to content

Studies

Master’s Degree in Biopharmaceutical Business

Download catalogue WhatsApp

The Master’s Degree in Biopharmaceutical Business is designed for students who wish to develop their professional potential in companies within the pharmaceutical, biotechnology, or medical technology sectors based on the demand these companies have for highly qualified professionals. Both IQS professors and more than 30 professionals from inside the industry will teach lessons and share real case studies related to global companies in this sector.

The objective of this master’s degree is to prepare new professionals who are ready to take on a wide variety of positions within the biopharmaceutical sector in an international work setting who are equipped with a cross-disciplinary technical and business vision of the different areas that make up this relevant industry.

  • Students will develop this professional vision based on the following objectives: acquiring knowledge about the functions, value chain, and technical, commercial, and financial aspects that are specific to the biopharmaceutical sector.
  • Students develop key competences such as analytical ability, critical thinking, leadership abilities, and managing teams.
  • Students apply the knowledge and skills they acquire to a real work environment through in-company internships.

Key information of the Master’s Degree in Biopharmaceutical Business

Duration

1 year

Credits

30 ECTS of curricular courses (1year)
30 ECTS curricular internships + Master’s Final Project

Start

October 2026

Timetable

6:00 pm to 9:00 pm Three days a week

Languages

English

Requirements

Bachelor’s degree in health sciences or individuals who wish to advance their career in the biotechnology or pharmaceutical industries.

Why study the Master’s Degree in Biopharmaceutical Business at IQS?

Mandatory in-company internships within the sector.

Development of leadership skills in parallel with the curriculum.

Taught by IQS professors and guest lecturers with extensive professional experience.

Guests speakers from the life sciences sector.

Facilities

More than 8,700 m2 of laboratories and workshops

At IQS, students work in laboratories and workshops equipped with the latest technologies. We have specific laboratories for the Master’s Degree in Biopharmaceutical Business, where you can put into practice everything you learn during your studies.

Objectives and competences of the Master’s Degree in Biopharmaceutical Business

See competences

Curriculum of the Master’s Degree in Biopharmaceutical Business

Module 1: The Global Biopharmaceutical Business

Module 2: Technical Areas. Development of New Treatments.

Module 3: Commercial and Managerial Aspects in the Biopharma Industry

Your career starts here

At IQS your professional and career expectations are greater because you’ll be in contact with the most cutting-edge companies in the sector from the very first day. The Master’s Degree in Biopharmaceutical Business will enable you to choose from among a wide array of jobs.

Career opportunities of the Master’s Degree in Biopharmaceutical Business

  • Clinical Development

  • MSL (Medical Scientific Liaison)

  • Sales Manager

  • Business Development

  • Intellectual Property

  • Regulatory Affairs

  • Market Access

In-company Internship of the Master’s Degree in Biopharmaceutical Business

The Master’s Degree in Biopharmaceutical Business features compulsory in-company internships (20 ECTS) within the biopharmaceutical sector for all students. IQS has agreements in place with various pharmaceutical, biotechnology, medical technology, and related services companies, all of which boast recognized prestige in the sector and offer students different positions in various departments depending on their needs. The in-company internships last for a minimum duration of six months.

Moreover, IQS hosts our own Job Exchange and a Career Services office that manages these in-company internships as well as provides career advice.

IQS Career Services

Partner companies

Admissions process of the Master’s Degree in Biopharmaceutical Business

Apply for admission

Once you have completed your registration, the system will assign you a user number then you must create a password. You can check the status of your application at any time with this login information.

If you are an IQS student, you must pre-register directly from your SIGMA profile. Enter your user name and password and go to official studies/pre-registration.

Documentation to upload

  • Your undergraduate degree, if you have finished your studies. If you studied outside the European Union, your degree must be apostilled and legalized for the enrolment step.
  • Your most up-to-date academic transcripts, with your grade point average on a scale of 0-10.
  • 1 passport-style photograph in colour with a white background in jpg format (176×220 pixels).
  • Photocopy of valid ID card on both sides or passport bio-data page.
  • Document certifying your English level as required in your programme of choice (see the Language requirements section in point number 5).
  • If you completed undergraduate studies outside the European Union that grant you access to graduate-level studies, you must provide a certificate issued by your home university confirming that the degree you earned enables you to access master’s degree studies in the country where your undergraduate degree was earned. You can download the certificate template here.

Payment:

  • Payment of €100 by credit or debit card to open and process your application.
  • It is only refunded in the event of non-admission.
  • If you make the payment from outside of Spain, you must do so through Flywire: www.flywire.com/pay/iqsland

 

The master’s degree coordinator will contact you for an interview. Subsequently, IQS will notify you by email on the decision regarding your admission.

Once admitted, you have a period of two weeks to make your pre-enrolment payment. You must pay a pre-enrolment tuition fee of €1,000. The pre-enrolment payment is non-refundable and does not entail an additional cost as it will be deducted from the total tuition fees once your enrolment is finalized.

 

If you make the payment from outside of Spain, you must do so through Flywire: www.flywire.com/pay/iqsland

 

If you are a non-EU student, you will receive your visa letter once IQS has received your pre-enrolment payment.

Once the enrolment period has opened, and if you have completed the previous stages, you will receive an email from the IQS Registrar’s Office with the credentials and instructions you need to proceed with your enrolment.

 

Using your credentials, start your session on the SIGMA academic management application and formalize your enrolment by indicating the payment method.

Prerequisites for admission

  • Hold a university undergraduate degree (or equivalent issued by a higher education institution within the European Higher Education Area) in the area of Health Sciences: Biotechnology, Pharmacy, Chemistry, Biochemistry, Biology, Medicine, or similar.
  • A university degree in other fields may be accepted as long as the student demonstrates great interest in building their career in the biopharmaceutical sector (each case will be assessed individually).

Scholarships and financial aid of the Master’s Degree in Biopharmaceutical Business

IQS offers scholarships and financial aid to students who wish to study a master’s degree at IQS and who have completed their undergraduate studies at another university. We also provide scholarships for academic excellence, financial need, and international students.

Visiting lecturers

Agustín Alconada, PhD

Representative before the Unified Patent Court ABG Intellectual Property

Alfons Carnicero

Co-founder and CEO at ABLE Human Motion

Ana da Costa, PhD

Manager Catenion

Bárbara Sánchez

AdQualis Human Results, General Manager

Cristopher Mann, PhD

Scientific & Regulatory Affairs Director – Asphalion

Eduard Melenchón

Market Insights & Analytics Consultant

Esther García Gil

VP, Global Clinical Development Almirall

Francesc Cartanyá

Chief People Officer, Familia Torres

Francisco Rodríguez, PhD

Scientific & Regulatory Affairs Manager Asphalion

Joachim RenkenPhD

Partner & CEO, Hoffmann Eitle, European Patent Attorney

Judith García

Global Safety Senior Manager, Amgen

Laura Rodríguez, PhD

Partner Invivo Partners

Lidia Cánovas

General manager, Regulatory Affairs Asphalion

Luis Ruiz, PhD

Aquilón Cyl SL, President

Mar Ramirez

Corporate Communications Manager – Boehringer Ingelheim

Marc Soriano, PhD

R&D Project Portfolio and Partnership Excellence Senior Director, Almirall

Marc MartinellPhD

Co-founder and CEO Mynoryx Therapeutics

Marcelo Carrera

Business Development Manager – Salvat

Marta PalicioPhD

Innovation R&D Director Werfen

Matthias KringsPhD

Senior Partner, Catenion

Nerea Blanqué

Partner pricing, access & Sustainability, Alira Health

Noelia Mateo, PhD

Global director Advanced Therapies, Business and Strategy – Hospital Clínic de Barcelona

Oriol Solà-MoralesPhD

CEO HITT – health Innovation technology Transfer

Pablo Martín-Sáiz

Chief R&D Officer Towa

Pío Orviz, PhD

Head of Intellectual Property Almirall

Teresa Tarragó, PhD

CEO Telara Pharma

Thomas Eichholtz, PhD

Independent Pharma and Biotech advisor

Viviana Belalcazar, PhD

QA Manager Biological Products – Almirall

Wendeline de Zan

Senior Educator and Coach

Download catalogue








The responsible for the treatment of your personal data is the Institut Químic de Sarrià CETS Private Foundation (IQS), CIF G58022849, with fiscal address at Via Augusta, 390, Barcelona (CP 08017). 
The purpose of the treatment is the management of your request and the sending of informative communications of our activities.
Rights: You can exercise your rights of access, rectification, deletion, portability, limitation or opposition in the treatment, by writing to the fiscal address of IQS reflected in the data of the person in charge or by sending an e-mail to dpoiqs@iqs.edu.
Additional information: You can consult additional information on this processing of personal data by referring to the IQS Data Privacy Policy.


También te puede interesar

Loading info...